Y-Biologics Secures U.S. Patent for Key ADC Antibody Co-Developed With Intocell

Amgen's PCSK9 Patent Battle: Legal Loss but Commercial Victory

This article examines Amgen's legal battle over PCSK9 cholesterol drugs, specifically their patent dispute with Sanofi and Regeneron. Amgen

RQ Bio secures $115M Series A for virus-targeting antibody pipeline

Benchmarking Codon Optimization Strategies for Improved Antibody Expression

This article/webinar promotion discusses how antibody expression titers are critical for screening efficiency, developability, and manufactu

China's biotech rise: A case study in multiple myeloma drug development

This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc

Panel Discussion—Biologics Breakthrough: Cutting Costs While Expanding Global Reach

Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs

Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The